Renal Anemia Therapeutics Market size to grow by USD 1.97 billion from 2021 to 2026, Driven by the presence of a large pool of CKD patients - Technavio

NEW YORK, April 7, 2023 /PRNewswire/ -- The renal anemia therapeutics market size is forecasted to increase by USD 1.97 billion from 2021 to 2026 at a CAGR of 8.25%, according to a recent market study by Technavio. The growth of the market will be driven by the presence of a large pool of CKD patients, new drug approvals, and the growing adoption of biosimilars. Technavio offers an up-to-date analysis of the current global market scenario and the overall market environment. View a Sample Report  

Renal Anemia Therapeutics Market - Vendor Analysis

The global renal anemia therapeutics market is subject to rapidly changing consumer demands and preferences. The changing consumer consumption patterns may affect vendor performance in the global renal anemia therapeutics market. It can also be affected by consumer tastes, global and regional economic conditions, and other demographic trends. AstraZeneca Plc, Akebia Therapeutics Inc., Amgen Inc., Bayer AG, Covis Pharma BV, Daiichi Sankyo Co. Ltd., Dr. Reddys Laboratories Ltd., F. Hoffmann La Roche Ltd., FibroGen Inc., GlaxoSmithKline Plc, JCR Pharmaceuticals Co. Ltd., JSC BIOCAD, Pfizer Inc., and Pharmacosmos AS are some of the major players in the market.

Vendor Offerings -

• AstraZeneca Plc - The company offers renal anemia therapeutics, namely Roxadustat. 
• Akebia Therapeutics Inc. - The company offers renal anemia therapeutics, namely Vadadustat. 
• Amgen Inc. - The company offers renal anemia therapeutics, namely Aranesp. 

Charts & data tables about market and segment sizes for the forecast period (2022-2026) have been covered in this report. Download the Sample Report

Key Benefits for Industry Players & Stakeholders – 

• The report offers information on the criticality of vendor inputs, including R&D, CAPEX, and technology.
• It also provides detailed analyses of the market's competitive landscape and vendors' product offerings.
• The report also provides a qualitative and quantitative analysis of vendors to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize vendors as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize vendors as dominant, leading, strong, tentative, and weak.

Expand operations in the future - To get requisite details, ask for a custom report.

Get a holistic overview of the endoscopic closure devices market from industry experts to evaluate and develop growth strategies. Download the Sample

Renal Anemia Therapeutics Market - Market Segmentation:

This report extensively covers renal anemia therapeutics market segmentation by application (IV and oral) and geography (North America, Europe, Asia, and the Rest of the World (ROW)).

• The market share growth by the IV segment will be significant for the growth of the renal anemia therapeutics market during the forecast period. These products are the least expensive IV iron drugs that can be administered in a large single dose. Hence, the high demand for renal anemia therapeutics is being bolstered by the increasing frequency of product approvals in the IV iron drugs segment. This results in the launch of several new drugs and will drive the growth of the IV drugs segment in the global renal anemia therapeutics market during the forecast period. 

Renal Anemia Therapeutics Market - Market Dynamics:

Key Drivers

• The presence of a large pool of CKD patients is one of the major drivers supporting the renal anemia therapeutics market growth. 
• The incidence rate of diabetes, high blood pressure, and other health conditions have increased in recent years, and individuals with these conditions are most prone to chronic kidney disease (CKD).
• Affected kidneys are unable to produce the required amount of erythropoietin (EPO) leading to a decline in the production of RBCs, which causes anemia.
• The low RBC production results in a reduced oxygen supply that is indicated by symptoms such as fatigue, dizziness, breathlessness, and chest pain. 
• This results in the increased need for renal anemia therapeutics, translating to higher sales for the renal anemia therapeutics market vendors.

Why Buy?

• Add credibility to strategy
• Analyzes competitor's offerings
• Get a holistic view of the market

Grow your profit margin with Technavio – Buy Now

Major Trends:

• The rising number of CKD dialysis centers in emerging economies is an emerging trend that is contributing to market growth.
• Vendors are investing in the renal anemia therapeutics market due to the increasing number of patients with CKD in emerging countries such as India, China, and others.
• Investments in emerging markets drive the number of dialysis centers. For instance, NephroPlus has announced an investment of USD 25 million in India to pursue growth opportunities across APAC. 
• Similarly, in August 2020, Renal Project, a healthcare start-up in India, raised USD 0.3 million from angel investors to fund its expansion plans.
• Such instances of growing CKD dialysis centers in emerging countries will propel the renal anemia therapeutics market growth during the forecast period.

Key Challenges:

• One of the factors hindering the renal anemia therapeutics market growth is the side effect of oral administration.
• Patients undergoing oral therapy can face poor gastrointestinal (GI) tolerance or absorption. 
• The therapeutics need to be administered in multiple doses, which are associated with numerous side effects, which limit the absorption of oral iron drugs into the patient's body.
• The protein restricts the absorption of iron from the intestine and limits the release of iron from macrophages and hepatocytes.
• Hence, such limitations are expected to hinder the renal anemia therapeutics market growth during the forecast period.

Drivers, trends, and challenges have an impact on market dynamics, which can impact businesses. Find more insights in a sample report!

What are the key data covered in this Renal Anemia Therapeutics Market report?

• CAGR of the market during the forecast period
• Detailed information on factors that will drive the growth of the renal anemia therapeutics market between 2022 and 2026
• Precise estimation of the size of the renal anemia therapeutics market and its contribution to the parent market
• Accurate predictions about upcoming trends and changes in consumer behavior
• Growth of the renal anemia therapeutics market across North America, Europe, Asia, and Rest of World (ROW)
• A thorough analysis of the market's competitive landscape and detailed information about vendors
• Comprehensive analysis of factors that will challenge the growth of the renal anemia therapeutics market vendors

Gain instant access to 17,000+ market research reports. 
Technavio's SUBSCRIPTION platform

Related Reports:

The renal biomarkers market size is expected to increase by USD 507.23 million from 2021 to 2026, at a CAGR of 7.40%. This renal biomarkers market research report extensively covers renal biomarkers market segmentation by end-user (hospitals, clinics and diagnostic laboratories, and research laboratories) and geography (North America, Europe, Asia, and ROW). The growing prevalence of chronic kidney diseases is one of the key drivers supporting renal biomarkers market growth. 

The gastrointestinal stromal tumors therapeutics market size is expected to increase by USD 1.08 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 5.97%. The report extensively covers the gastrointestinal stromal tumors therapeutics market segmentation by route of administration (oral and parenteral) and geography (North America, Europe, Asia, and the Rest of the World (ROW)). The growing geriatric population is one of the factors driving the gastrointestinal stromal tumors therapeutics (GIST) market growth.

Browse for Technavio's Consumer Discretionary Market Reports      

Table of contents  

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary – Chart on Market Overview
• Exhibit 02: Executive Summary – Data Table on Market Overview
• Exhibit 03: Executive Summary – Chart on Global Market Characteristics
• Exhibit 04: Executive Summary – Chart on Market by Geography
• Exhibit 05: Executive Summary – Chart on Market Segmentation by End-user
• Exhibit 06: Executive Summary – Chart on Market Segmentation by Deployment
• Exhibit 07: Executive Summary – Chart on Incremental Growth
• Exhibit 08: Executive Summary – Data Table on Incremental Growth
• Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 10: Parent market
• Exhibit 11: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 12: Offerings of vendors included in the market definition

• 3.2 Market segment analysis
• Exhibit 13: Market segments

• 3.3 Market size 2021

• 3.4 Market outlook: Forecast for 2021-2026
• Exhibit 14: Chart on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 15: Data Table on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 16: Chart on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibit 17: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

• 4.1 Five forces summary
• Exhibit 18: Five forces analysis - Comparison between 2021 and 2026

• 4.2 Bargaining power of buyers
• Exhibit 19: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026

• 4.3 Bargaining power of suppliers
• Exhibit 20: Bargaining power of suppliers – Impact of key factors in 2021 and 2026

• 4.4 Threat of new entrants
• Exhibit 21: Threat of new entrants – Impact of key factors in 2021 and 2026

• 4.5 Threat of substitutes
• Exhibit 22: Threat of substitutes – Impact of key factors in 2021 and 2026

• 4.6 Threat of rivalry
• Exhibit 23: Threat of rivalry – Impact of key factors in 2021 and 2026

• 4.7 Market condition
• Exhibit 24: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by End-user

• 5.1 Market segments
• Exhibit 25: Chart on End-user - Market share 2021-2026 (%)
• Exhibit 26: Data Table on End-user - Market share 2021-2026 (%)

• 5.2 Comparison by End-user
• Exhibit 27: Chart on Comparison by End-user
• Exhibit 28: Data Table on Comparison by End-user

• 5.3 Non-academic learners - Market size and forecast 2021-2026
• Exhibit 29: Chart on Non-academic learners - Market size and forecast 2021-2026 ($ million)
• Exhibit 30: Data Table on Non-academic learners - Market size and forecast 2021-2026 ($ million)
• Exhibit 31: Chart on Non-academic learners - Year-over-year growth 2021-2026 (%)
• Exhibit 32: Data Table on Non-academic learners - Year-over-year growth 2021-2026 (%)

• 5.4 Academic learners - Market size and forecast 2021-2026
• Exhibit 33: Chart on Academic learners - Market size and forecast 2021-2026 ($ million)
• Exhibit 34: Data Table on Academic learners - Market size and forecast 2021-2026 ($ million)
• Exhibit 35: Chart on Academic learners - Year-over-year growth 2021-2026 (%)
• Exhibit 36: Data Table on Academic learners - Year-over-year growth 2021-2026 (%)

• 5.5 Market opportunity by End-user
• Exhibit 37: Market opportunity by End-user ($ million)

6 Market Segmentation by Deployment

• 6.1 Market segments
• Exhibit 38: Chart on Deployment - Market share 2021-2026 (%)
• Exhibit 39: Data Table on Deployment - Market share 2021-2026 (%)

• 6.2 Comparison by Deployment
• Exhibit 40: Chart on Comparison by Deployment
• Exhibit 41: Data Table on Comparison by Deployment

• 6.3 On-premise - Market size and forecast 2021-2026
• Exhibit 42: Chart on On-premise - Market size and forecast 2021-2026 ($ million)
• Exhibit 43: Data Table on On-premise - Market size and forecast 2021-2026 ($ million)
• Exhibit 44: Chart on On-premise - Year-over-year growth 2021-2026 (%)
• Exhibit 45: Data Table on On-premise - Year-over-year growth 2021-2026 (%)

• 6.4 Cloud-based - Market size and forecast 2021-2026
• Exhibit 46: Chart on Cloud-based - Market size and forecast 2021-2026 ($ million)
• Exhibit 47: Data Table on Cloud-based - Market size and forecast 2021-2026 ($ million)
• Exhibit 48: Chart on Cloud-based - Year-over-year growth 2021-2026 (%)
• Exhibit 49: Data Table on Cloud-based - Year-over-year growth 2021-2026 (%)

• 6.5 Market opportunity by Deployment
• Exhibit 50: Market opportunity by Deployment ($ million)

7 Customer Landscape

• 7.1 Customer landscape overview
• Exhibit 51: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

8 Geographic Landscape

• 8.1 Geographic segmentation
• Exhibit 52: Chart on Market share by geography 2021-2026 (%)
• Exhibit 53: Data Table on Market share by geography 2021-2026 (%)

• 8.2 Geographic comparison
• Exhibit 54: Chart on Geographic comparison
• Exhibit 55: Data Table on Geographic comparison

• 8.3 APAC - Market size and forecast 2021-2026
• Exhibit 56: Chart on APAC - Market size and forecast 2021-2026 ($ million)
• Exhibit 57: Data Table on APAC - Market size and forecast 2021-2026 ($ million)
• Exhibit 58: Chart on APAC - Year-over-year growth 2021-2026 (%)
• Exhibit 59: Data Table on APAC - Year-over-year growth 2021-2026 (%)

• 8.4 Europe - Market size and forecast 2021-2026
• Exhibit 60: Chart on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 61: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 62: Chart on Europe - Year-over-year growth 2021-2026 (%)
• Exhibit 63: Data Table on Europe - Year-over-year growth 2021-2026 (%)

• 8.5 North America - Market size and forecast 2021-2026
• Exhibit 64: Chart on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 65: Data Table on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 66: Chart on North America - Year-over-year growth 2021-2026 (%)
• Exhibit 67: Data Table on North America - Year-over-year growth 2021-2026 (%)

• 8.6 South America - Market size and forecast 2021-2026
• Exhibit 68: Chart on South America - Market size and forecast 2021-2026 ($ million)
• Exhibit 69: Data Table on South America - Market size and forecast 2021-2026 ($ million)
• Exhibit 70: Chart on South America - Year-over-year growth 2021-2026 (%)
• Exhibit 71: Data Table on South America - Year-over-year growth 2021-2026 (%)

• 8.7 Middle East and Africa - Market size and forecast 2021-2026
• Exhibit 72: Chart on Middle East and Africa - Market size and forecast 2021-2026 ($ million)
• Exhibit 73: Data Table on Middle East and Africa - Market size and forecast 2021-2026 ($ million)
• Exhibit 74: Chart on Middle East and Africa - Year-over-year growth 2021-2026 (%)
• Exhibit 75: Data Table on Middle East and Africa - Year-over-year growth 2021-2026 (%)

• 8.8 China - Market size and forecast 2021-2026
• Exhibit 76: Chart on China - Market size and forecast 2021-2026 ($ million)
• Exhibit 77: Data Table on China - Market size and forecast 2021-2026 ($ million)
• Exhibit 78: Chart on China - Year-over-year growth 2021-2026 (%)
• Exhibit 79: Data Table on China - Year-over-year growth 2021-2026 (%)

• 8.9 US - Market size and forecast 2021-2026
• Exhibit 80: Chart on US - Market size and forecast 2021-2026 ($ million)
• Exhibit 81: Data Table on US - Market size and forecast 2021-2026 ($ million)
• Exhibit 82: Chart on US - Year-over-year growth 2021-2026 (%)
• Exhibit 83: Data Table on US - Year-over-year growth 2021-2026 (%)

• 8.10 UK - Market size and forecast 2021-2026
• Exhibit 84: Chart on UK - Market size and forecast 2021-2026 ($ million)
• Exhibit 85: Data Table on UK - Market size and forecast 2021-2026 ($ million)
• Exhibit 86: Chart on UK - Year-over-year growth 2021-2026 (%)
• Exhibit 87: Data Table on UK - Year-over-year growth 2021-2026 (%)

• 8.11 India - Market size and forecast 2021-2026
• Exhibit 88: Chart on India - Market size and forecast 2021-2026 ($ million)
• Exhibit 89: Data Table on India - Market size and forecast 2021-2026 ($ million)
• Exhibit 90: Chart on India - Year-over-year growth 2021-2026 (%)
• Exhibit 91: Data Table on India - Year-over-year growth 2021-2026 (%)

• 8.12 Germany - Market size and forecast 2021-2026
• Exhibit 92: Chart on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibit 93: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibit 94: Chart on Germany - Year-over-year growth 2021-2026 (%)
• Exhibit 95: Data Table on Germany - Year-over-year growth 2021-2026 (%)

• 8.13 Market opportunity by geography
• Exhibit 96: Market opportunity by geography ($ million)

9 Drivers, Challenges, and Trends

• 9.1 Market drivers

• 9.2 Market challenges

• 9.3 Impact of drivers and challenges
• Exhibit 97: Impact of drivers and challenges in 2021 and 2026

• 9.4 Market trends

10 Vendor Landscape

• 10.1 Overview

• 10.2 Vendor landscape
• Exhibit 98: Overview on Criticality of inputs and Factors of differentiation

• 10.3 Landscape disruption
• Exhibit 99: Overview on factors of disruption

• 10.4 Industry risks
• Exhibit 100: Impact of key risks on business

11 Vendor Analysis

• 11.1 Vendors covered
• Exhibit 101: Vendors covered

• 11.2 Market positioning of vendors
• Exhibit 102: Matrix on vendor position and classification

• 11.3 Cambridge University Press
• Exhibit 103: Cambridge University Press - Overview
• Exhibit 104: Cambridge University Press - Product / Service
• Exhibit 105: Cambridge University Press - Key offerings

• 11.4 Cengage Learning Holdings II Inc.
• Exhibit 106: Cengage Learning Holdings II Inc. - Overview
• Exhibit 107: Cengage Learning Holdings II Inc. - Business segments
• Exhibit 108: Cengage Learning Holdings II Inc. - Key offerings
• Exhibit 109: Cengage Learning Holdings II Inc. - Segment focus

• 11.5 EF Education First Ltd.
• Exhibit 110: EF Education First Ltd. - Overview
• Exhibit 111: EF Education First Ltd. - Product / Service
• Exhibit 112: EF Education First Ltd. - Key offerings

• 11.6 Houghton Mifflin Harcourt Co.
• Exhibit 113: Houghton Mifflin Harcourt Co. - Overview
• Exhibit 114: Houghton Mifflin Harcourt Co. - Business segments
• Exhibit 115: Houghton Mifflin Harcourt Co. - Key offerings
• Exhibit 116: Houghton Mifflin Harcourt Co. - Segment focus

• 11.7 IXL Learning Inc.
• Exhibit 117: IXL Learning Inc. - Overview
• Exhibit 118: IXL Learning Inc. - Product / Service
• Exhibit 119: IXL Learning Inc. - Key offerings

• 11.8 John Wiley and Sons Inc.
• Exhibit 120: John Wiley and Sons Inc. - Overview
• Exhibit 121: John Wiley and Sons Inc. - Business segments
• Exhibit 122: John Wiley and Sons Inc. - Key offerings
• Exhibit 123: John Wiley and Sons Inc. - Segment focus

• 11.9 New Oriental Education and Technology Group Inc.
• Exhibit 124: New Oriental Education and Technology Group Inc. - Overview
• Exhibit 125: New Oriental Education and Technology Group Inc. - Business segments
• Exhibit 126: New Oriental Education and Technology Group Inc. - Key offerings
• Exhibit 127: New Oriental Education and Technology Group Inc. - Segment focus

• 11.10 Oxford University Press
• Exhibit 128: Oxford University Press - Overview
• Exhibit 129: Oxford University Press - Business segments
• Exhibit 130: Oxford University Press - Key offerings
• Exhibit 131: Oxford University Press - Segment focus

• 11.11 Pearson Plc
• Exhibit 132: Pearson Plc - Overview
• Exhibit 133: Pearson Plc - Business segments
• Exhibit 134: Pearson Plc - Key offerings
• Exhibit 135: Pearson Plc - Segment focus

• 11.12 Sanako Oy
• Exhibit 136: Sanako Oy - Overview
• Exhibit 137: Sanako Oy - Product / Service
• Exhibit 138: Sanako Oy - Key offerings

12 Appendix

• 12.1 Scope of the report

• 12.2 Inclusions and exclusions checklist
• Exhibit 139: Inclusions checklist
• Exhibit 140: Exclusions checklist

• 12.3 Currency conversion rates for US$
• Exhibit 141: Currency conversion rates for US$

• 12.4 Research methodology
• Exhibit 142: Research methodology
• Exhibit 143: Validation techniques employed for market sizing
• Exhibit 144: Information sources

• 12.5 List of abbreviations
• Exhibit 145: List of abbreviations

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

SOURCE Technavio